Covishield
Serum Institute says Covishield production increased to 110 million doses in July
Pune/IBNS: Serum Institute of India (SII) said Tuesday the production of Covishield has been ramped up to 110 million doses this month, according to media reports.
"The commitment to produce 100-110 million doses of Covishield by July has been achieved," Serum Institute sources told NDTV.
Additionally, SII is also going to produce Russia's Sputnik V vaccine from September and it is also gearing up to rollout of the Covovax (Novavax) vaccine, which is yet to get Emergency Use Authorisation.
Currently, Covishield and Covaxin are the two vaccines used in India's massive Covid-19 vaccination drive.
The Central government aims to vaccinate all adults by the end of 2021.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
